Altered elastase-alpha1-antitrypsin balance in the blood of patients with chronic venous disease

Phlebology. 2016 Mar;31(2):125-32. doi: 10.1177/0268355515569559. Epub 2015 Jan 27.

Abstract

Objectives: Although leukocyte elastase is suspected to be involved in the damage of vein wall during chronic venous disease, the equilibrium between this protease and its inhibitor, alpha1-antitrypsin, has not yet been evaluated. The aim of the present study was to determine the relationship between leukocyte elastase and alpha1-antitrypsin, in the blood of patients with chronic venous disease.

Patients and methods: The concentration and the activity of leukocyte elastase along with the activity of alpha1-antitrypsin were evaluated in the blood of 55 chronic venous disease patients. The results were compared with those obtained in 33 healthy age and sex-matched volunteers.

Results: A significant decrease in the leukocyte elastase activity that correlated with an increased alpha1-antitrypsin activity was observed in the serum of patients with mild clinical symptoms of chronic venous disease.

Conclusions: The results of the study did not confirm a hypothesis about an important role of proteolytic activity of leukocyte elastase in the vein wall injury mechanism. They show that the leukocyte elastase-alpha1-antitrypsin balance is rather shifted toward antiprotease activity, especially in an early stage of chronic venous disease.

Keywords: Chronic venous disease; alpha1-antitrypsin; elastase; varicose veins.

MeSH terms

  • Adult
  • Aged
  • Chronic Disease
  • Female
  • Humans
  • Leukocyte Elastase / blood*
  • Male
  • Middle Aged
  • Vascular Diseases / blood*
  • alpha 1-Antitrypsin / blood*

Substances

  • alpha 1-Antitrypsin
  • alpha 1-antitrypsin-leukocyte elastase complex
  • Leukocyte Elastase